These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7923093

  • 1. Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer.
    Halmos G, Pinski J, Szoke B, Schally AV.
    Cancer Lett; 1994 Sep 30; 85(1):111-8. PubMed ID: 7923093
    [Abstract] [Full Text] [Related]

  • 2. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.
    Qin Y, Halmos G, Cai RZ, Szoke B, Ertl T, Schally AV.
    J Cancer Res Clin Oncol; 1994 Sep 30; 120(9):519-28. PubMed ID: 8045917
    [Abstract] [Full Text] [Related]

  • 3. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G, Wittliff JL, Schally AV.
    Cancer Res; 1995 Jan 15; 55(2):280-7. PubMed ID: 7812958
    [Abstract] [Full Text] [Related]

  • 4. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
    Reile H, Armatis PE, Schally AV.
    Prostate; 1994 Jul 15; 25(1):29-38. PubMed ID: 8022709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
    Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, Schally AV.
    Int J Cancer; 1994 May 15; 57(4):574-80. PubMed ID: 7910153
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a bombesin/gastrin-releasing peptide receptor on a human gastric-cancer cell line.
    Preston SR, Woodhouse LF, Gokhale J, Miller GV, Primrose JN.
    Int J Cancer; 1994 Jun 01; 57(5):734-41. PubMed ID: 8194883
    [Abstract] [Full Text] [Related]

  • 8. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY, Schonbrunn A.
    Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The binding of bombesin and somatostatin and their analogs to human colon cancers.
    Radulovic SS, Milovanovic SR, Cai RZ, Schally AV.
    Proc Soc Exp Biol Med; 1992 Jul 01; 200(3):394-401. PubMed ID: 1352046
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interaction of [125I]-Tyr4-bombesin with specific receptors on normal human pancreatic membranes.
    Scemama JL, Zahidi A, Fourmy D, Fagot-Revurat P, Vaysse N, Pradayrol L, Ribet A.
    Regul Pept; 1986 Jan 01; 13(2):125-32. PubMed ID: 3006155
    [Abstract] [Full Text] [Related]

  • 13. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa.
    Preston SR, Woodhouse LF, Jones-Blackett S, Miller GV, Primrose JN.
    Br J Cancer; 1995 May 01; 71(5):1087-9. PubMed ID: 7734305
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin.
    Brown KD, Laurie MS, Littlewood CJ, Blakeley DM, Corps AN.
    Biochem J; 1988 May 15; 252(1):227-35. PubMed ID: 2844145
    [Abstract] [Full Text] [Related]

  • 15. Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides.
    Sinnett-Smith J, Lehmann W, Rozengurt E.
    Biochem J; 1990 Jan 15; 265(2):485-93. PubMed ID: 2154190
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Kahán Z, Sun B, Schally AV, Arencibia JM, Cai RZ, Groot K, Halmos G.
    Cancer; 2000 Mar 15; 88(6):1384-92. PubMed ID: 10717621
    [Abstract] [Full Text] [Related]

  • 17. High-affinity binding sites for bombesin on mouse colonic mucosal membranes.
    Narayan S, Draviam E, Rajaraman S, Singh P.
    Mol Cell Biochem; 1991 Jul 24; 106(1):31-9. PubMed ID: 1656207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
    Radulovic S, Schally AV, Reile H, Halmos G, Szepeshazi K, Groot K, Milovanovic S, Miller G, Yano T.
    Acta Oncol; 1994 Jul 24; 33(6):693-701. PubMed ID: 7946450
    [Abstract] [Full Text] [Related]

  • 20. Receptors for GRP/bombesin-like peptides in the rat forebrain.
    Wolf SS, Moody TW.
    Peptides; 1985 Jul 24; 6 Suppl 1():111-4. PubMed ID: 2995940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.